Equities

Medipal Holdings Corp

Medipal Holdings Corp

Actions
Consumer Staples Personal Care, Drug and Grocery Stores
  • Price (JPY)1,905.00
  • Today's Change13.00 / 0.69%
  • Shares traded624.70k
  • 1 Year change-9.20%
  • Beta0.6505
Data delayed at least 20 minutes, as of Aug 05 2022 07:00 BST.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Profile data is unavailable for this security.

About the company

MEDIPAL HOLDINGS CORPORATION engages in the wholesale of pharmaceutical products, cosmetics and daily miscellaneous goods. The Company operates in three segments. The Ethical Pharmaceutical Wholesale segment is involved in the wholesale of pharmaceutical products, medical equipment and test reagents, the distribution and planning of specialty drugs, the construction of medical material database and others. The Cosmetics, Daily Product and General Medicine Wholesale segment is engaged in the wholesale of cosmetics, daily miscellaneous goods and general pharmaceuticals. The Veterinary Medicine and Food Processing Raw Materials Wholesale segment is engaged in the wholesale of veterinary products, food additives and food raw materials. The Company is also involved in the provision of cleaning services, the management and operation of logistics centers, the provision of manpower dispatching services and others.

  • Revenue in JPY (TTM)3.30tn
  • Net income in JPY28.25bn
  • Incorporated1923
  • Employees12.80k
  • Location
    Medipal Holdings Corp2-7-15, YaesuCHUO-KU 104-8461JapanJPN
  • Phone+81 335175800
  • Fax+81 335175028
  • Websitehttps://www.medipal.co.jp/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
TAKARA BIO INC.66.53bn17.73bn257.60bn1.67k14.572.6311.693.87147.25147.25552.50815.460.63021.175.2139,933,370.0016.869.9419.4411.1669.4465.3726.7618.173.6239.33--21.0346.9018.17107.9171.1452.5752.51
Hisamitsu Pharmaceutical Co Inc118.83bn8.93bn294.67bn2.78k31.261.1021.742.48110.68110.681,471.373,133.610.39112.773.6942,681,390.003.025.153.435.8357.4161.167.7211.524.20--0.00544.974.96-3.814.41-13.895.560.6061
JCR Pharmaceuticals Co Ltd50.88bn14.34bn319.68bn816.0021.356.0122.126.28115.47115.47409.61410.130.60290.76414.9862,346,810.0017.0111.4728.7116.2777.8573.5828.2120.621.17--0.26222.4669.7923.08110.4950.7548.8629.46
Alfresa Holdings Corporation2.60tn31.06bn355.60bn11.93k11.830.75469.190.1368149.77149.7712,542.822,348.241.9516.384.25217,960,500.002.342.636.067.047.187.401.201.331.07--0.0000629.60-0.94940.263831.350.82094.548.45
Sumitomo Pharma Co Ltd588.72bn82.72bn409.97bn6.99k4.990.61333.740.6964208.20208.201,481.781,693.990.43611.603.6484,258,620.005.034.106.845.9772.0273.8511.538.671.39--0.265421.778.546.520.345112.490.0529.24
Santen Pharmaceutical Co Ltd266.80bn26.54bn430.21bn4.32k16.221.239.721.6166.4266.42667.71873.790.62172.772.7561,831,750.006.196.257.557.5658.3460.559.9510.302.03--0.151243.856.675.99192.384.6030.424.24
ROHTO PHARMACEUTICAL CO., LTD.199.65bn21.02bn469.99bn6.87k21.662.5516.312.35183.72183.721,745.161,562.980.79742.714.0129,077,480.008.456.7711.549.5258.3559.2910.597.831.83--0.119821.6110.135.2525.5315.9923.2711.38
Medipal Holdings Corp3.30tn28.25bn490.27bn12.80k15.900.78129.500.1484126.13126.1314,797.152,566.731.9419.674.52258,133,900.002.212.606.267.266.617.021.141.321.05--0.043626.652.481.4422.980.2824-12.037.26
Nippon Shinyaku Co., Ltd.137.48bn24.99bn577.47bn2.13k22.163.0719.524.20370.97370.972,041.252,681.190.64641.363.3464,698,350.0011.7510.1913.9412.0663.4957.6918.1815.323.49--0.014830.9812.826.8427.8716.2915.4918.04
Data as of Aug 05 2022. Currency figures normalised to Medipal Holdings Corp's reporting currency: Japanese Yen JPY

Institutional shareholders

19.30%Per cent of shares held by top holders
HolderShares% Held
Silchester International Investors LLPas of 26 Jul 202220.02m8.19%
Nomura Asset Management Co., Ltd.as of 31 May 20227.52m3.08%
The Vanguard Group, Inc.as of 08 Jul 20223.84m1.57%
Norges Bank Investment Managementas of 31 Dec 20213.00m1.23%
Daiwa Asset Management Co. Ltd.as of 30 Jun 20223.00m1.23%
Nikko Asset Management Co., Ltd.as of 08 Jul 20222.95m1.21%
Geode Capital Management LLCas of 07 Jul 20222.05m0.84%
BlackRock Fund Advisorsas of 07 Jul 20221.99m0.81%
Mitsubishi UFJ Kokusai Asset Management Co., Ltd.as of 07 Jul 20221.56m0.64%
Dimensional Fund Advisors LPas of 07 Jul 20221.27m0.52%
More ▼
Data from 31 Dec 2021 - 30 Jun 2022Source: FactSet Research Systems Inc.
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.